Industry Research Reports

Home > Reports > Pharma & Healthcare > Liver Cirrhosis Therapeutics Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Liver Cirrhosis Therapeutics Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 143 Pages

Report ld: 2343505

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Liver Cirrhosis Therapeutics Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Cirrhosis Therapeutics Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liver Cirrhosis Therapeutics Drugs by region & country, by Type, and by Application.

The Liver Cirrhosis Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cirrhosis Therapeutics Drugs.

Market Segmentation

Report Metric
Details
Report Title
Liver Cirrhosis Therapeutics Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Liver Cirrhosis Therapeutics Drugs Companies Covered
Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Pharmicell, Salix Pharmaceuticals, Stempeutics Research
Global Liver Cirrhosis Therapeutics Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Cirrhosis Therapeutics Drugs Market, Segment by Type
Oral Liver Cirrhosis Therapeutics Drugs

Injection Liver Cirrhosis Therapeutics Drugs
Global Liver Cirrhosis Therapeutics Drugs Market, Segment by Application
Hospitals

Clinics

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liver Cirrhosis Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Liver Cirrhosis Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Liver Cirrhosis Therapeutics Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Liver Cirrhosis Therapeutics Drugs Product Introduction
    1.2 Global Liver Cirrhosis Therapeutics Drugs Market Size Forecast
        1.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030)
        1.2.2 Global Liver Cirrhosis Therapeutics Drugs Sales Volume (2019-2030)
        1.2.3 Global Liver Cirrhosis Therapeutics Drugs Sales Price (2019-2030)
    1.3 Liver Cirrhosis Therapeutics Drugs Market Trends & Drivers
        1.3.1 Liver Cirrhosis Therapeutics Drugs Industry Trends
        1.3.2 Liver Cirrhosis Therapeutics Drugs Market Drivers & Opportunity
        1.3.3 Liver Cirrhosis Therapeutics Drugs Market Challenges
        1.3.4 Liver Cirrhosis Therapeutics Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Liver Cirrhosis Therapeutics Drugs Players Revenue Ranking (2023)
    2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Company (2019-2024)
    2.3 Global Liver Cirrhosis Therapeutics Drugs Players Sales Volume Ranking (2023)
    2.4 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Liver Cirrhosis Therapeutics Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Liver Cirrhosis Therapeutics Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Liver Cirrhosis Therapeutics Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Liver Cirrhosis Therapeutics Drugs
    2.9 Liver Cirrhosis Therapeutics Drugs Market Competitive Analysis
        2.9.1 Liver Cirrhosis Therapeutics Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Liver Cirrhosis Therapeutics Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cirrhosis Therapeutics Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral Liver Cirrhosis Therapeutics Drugs
        3.1.2 Injection Liver Cirrhosis Therapeutics Drugs
    3.2 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type
        3.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Liver Cirrhosis Therapeutics Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Liver Cirrhosis Therapeutics Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type
        3.3.1 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Liver Cirrhosis Therapeutics Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Liver Cirrhosis Therapeutics Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Liver Cirrhosis Therapeutics Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Other
    4.2 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application
        4.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Liver Cirrhosis Therapeutics Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Liver Cirrhosis Therapeutics Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application
        4.3.1 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Liver Cirrhosis Therapeutics Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Liver Cirrhosis Therapeutics Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Liver Cirrhosis Therapeutics Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region
        5.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region
        5.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Liver Cirrhosis Therapeutics Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        5.4.2 North America Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        5.5.2 Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        5.7.2 South America Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value
        6.2.1 Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.3.2 United States Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.4.2 Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.5.2 China Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.6.2 Japan Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.7.2 South Korea Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Liver Cirrhosis Therapeutics Drugs Sales Value, 2019-2030
        6.9.2 India Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Liver Cirrhosis Therapeutics Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Company Information
        7.1.2 Gilead Sciences Introduction and Business Overview
        7.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.1.5 Gilead Sciences Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Information
        7.2.2 GlaxoSmithKline Introduction and Business Overview
        7.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Information
        7.3.2 Johnson & Johnson Introduction and Business Overview
        7.3.3 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.3.5 Johnson & Johnson Recent Development
    7.4 Merck
        7.4.1 Merck Company Information
        7.4.2 Merck Introduction and Business Overview
        7.4.3 Merck Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Merck Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.4.5 Merck Recent Development
    7.5 Roche
        7.5.1 Roche Company Information
        7.5.2 Roche Introduction and Business Overview
        7.5.3 Roche Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Roche Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.5.5 Roche Recent Development
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Company Information
        7.6.2 Bristol-Myers Squibb Introduction and Business Overview
        7.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.6.5 Bristol-Myers Squibb Recent Development
    7.7 Conatus Pharmaceuticals
        7.7.1 Conatus Pharmaceuticals Company Information
        7.7.2 Conatus Pharmaceuticals Introduction and Business Overview
        7.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.7.5 Conatus Pharmaceuticals Recent Development
    7.8 Gwo Xi Stem Cell Applied Technology
        7.8.1 Gwo Xi Stem Cell Applied Technology Company Information
        7.8.2 Gwo Xi Stem Cell Applied Technology Introduction and Business Overview
        7.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
    7.9 Instituto Grifols
        7.9.1 Instituto Grifols Company Information
        7.9.2 Instituto Grifols Introduction and Business Overview
        7.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.9.5 Instituto Grifols Recent Development
    7.10 Intercept Pharmaceuticals
        7.10.1 Intercept Pharmaceuticals Company Information
        7.10.2 Intercept Pharmaceuticals Introduction and Business Overview
        7.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.10.5 Intercept Pharmaceuticals Recent Development
    7.11 NGM Biopharmaceuticals
        7.11.1 NGM Biopharmaceuticals Company Information
        7.11.2 NGM Biopharmaceuticals Introduction and Business Overview
        7.11.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.11.5 NGM Biopharmaceuticals Recent Development
    7.12 Norgine
        7.12.1 Norgine Company Information
        7.12.2 Norgine Introduction and Business Overview
        7.12.3 Norgine Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Norgine Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.12.5 Norgine Recent Development
    7.13 Pharmicell
        7.13.1 Pharmicell Company Information
        7.13.2 Pharmicell Introduction and Business Overview
        7.13.3 Pharmicell Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Pharmicell Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.13.5 Pharmicell Recent Development
    7.14 Salix Pharmaceuticals
        7.14.1 Salix Pharmaceuticals Company Information
        7.14.2 Salix Pharmaceuticals Introduction and Business Overview
        7.14.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.14.5 Salix Pharmaceuticals Recent Development
    7.15 Stempeutics Research
        7.15.1 Stempeutics Research Company Information
        7.15.2 Stempeutics Research Introduction and Business Overview
        7.15.3 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Product Offerings
        7.15.5 Stempeutics Research Recent Development

 8 Industry Chain Analysis
    8.1 Liver Cirrhosis Therapeutics Drugs Industrial Chain
    8.2 Liver Cirrhosis Therapeutics Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Liver Cirrhosis Therapeutics Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Liver Cirrhosis Therapeutics Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Liver Cirrhosis Therapeutics Drugs Market Trends
    Table 2. Liver Cirrhosis Therapeutics Drugs Market Drivers & Opportunity
    Table 3. Liver Cirrhosis Therapeutics Drugs Market Challenges
    Table 4. Liver Cirrhosis Therapeutics Drugs Market Restraints
    Table 5. Global Liver Cirrhosis Therapeutics Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Liver Cirrhosis Therapeutics Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Liver Cirrhosis Therapeutics Drugs Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Liver Cirrhosis Therapeutics Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Liver Cirrhosis Therapeutics Drugs
    Table 13. Global Liver Cirrhosis Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cirrhosis Therapeutics Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Liver Cirrhosis Therapeutics Drugs Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Liver Cirrhosis Therapeutics Drugs Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Liver Cirrhosis Therapeutics Drugs Price by Application (2019-2024) & (USD/Pcs)
    Table 39. Global Liver Cirrhosis Therapeutics Drugs Price by Application (2025-2030) & (USD/Pcs)
    Table 40. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Liver Cirrhosis Therapeutics Drugs Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Liver Cirrhosis Therapeutics Drugs Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Gilead Sciences Company Information
    Table 58. Gilead Sciences Introduction and Business Overview
    Table 59. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 61. Gilead Sciences Recent Development
    Table 62. GlaxoSmithKline Company Information
    Table 63. GlaxoSmithKline Introduction and Business Overview
    Table 64. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Johnson & Johnson Company Information
    Table 68. Johnson & Johnson Introduction and Business Overview
    Table 69. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 71. Johnson & Johnson Recent Development
    Table 72. Merck Company Information
    Table 73. Merck Introduction and Business Overview
    Table 74. Merck Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Merck Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 76. Merck Recent Development
    Table 77. Roche Company Information
    Table 78. Roche Introduction and Business Overview
    Table 79. Roche Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. Roche Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 81. Roche Recent Development
    Table 82. Bristol-Myers Squibb Company Information
    Table 83. Bristol-Myers Squibb Introduction and Business Overview
    Table 84. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. Conatus Pharmaceuticals Company Information
    Table 88. Conatus Pharmaceuticals Introduction and Business Overview
    Table 89. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 91. Conatus Pharmaceuticals Recent Development
    Table 92. Gwo Xi Stem Cell Applied Technology Company Information
    Table 93. Gwo Xi Stem Cell Applied Technology Introduction and Business Overview
    Table 94. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 96. Gwo Xi Stem Cell Applied Technology Recent Development
    Table 97. Instituto Grifols Company Information
    Table 98. Instituto Grifols Introduction and Business Overview
    Table 99. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 101. Instituto Grifols Recent Development
    Table 102. Intercept Pharmaceuticals Company Information
    Table 103. Intercept Pharmaceuticals Introduction and Business Overview
    Table 104. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 105. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 106. Intercept Pharmaceuticals Recent Development
    Table 107. NGM Biopharmaceuticals Company Information
    Table 108. NGM Biopharmaceuticals Introduction and Business Overview
    Table 109. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 111. NGM Biopharmaceuticals Recent Development
    Table 112. Norgine Company Information
    Table 113. Norgine Introduction and Business Overview
    Table 114. Norgine Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. Norgine Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 116. Norgine Recent Development
    Table 117. Pharmicell Company Information
    Table 118. Pharmicell Introduction and Business Overview
    Table 119. Pharmicell Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. Pharmicell Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 121. Pharmicell Recent Development
    Table 122. Salix Pharmaceuticals Company Information
    Table 123. Salix Pharmaceuticals Introduction and Business Overview
    Table 124. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 126. Salix Pharmaceuticals Recent Development
    Table 127. Stempeutics Research Company Information
    Table 128. Stempeutics Research Introduction and Business Overview
    Table 129. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Product Offerings
    Table 131. Stempeutics Research Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Liver Cirrhosis Therapeutics Drugs Downstream Customers
    Table 135. Liver Cirrhosis Therapeutics Drugs Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liver Cirrhosis Therapeutics Drugs Product Picture
    Figure 2. Global Liver Cirrhosis Therapeutics Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Liver Cirrhosis Therapeutics Drugs Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Liver Cirrhosis Therapeutics Drugs Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Liver Cirrhosis Therapeutics Drugs Report Years Considered
    Figure 7. Global Liver Cirrhosis Therapeutics Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Liver Cirrhosis Therapeutics Drugs Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Cirrhosis Therapeutics Drugs Revenue in 2023
    Figure 10. Liver Cirrhosis Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Liver Cirrhosis Therapeutics Drugs Picture
    Figure 12. Injection Liver Cirrhosis Therapeutics Drugs Picture
    Figure 13. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Liver Cirrhosis Therapeutics Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 16. Global Liver Cirrhosis Therapeutics Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Liver Cirrhosis Therapeutics Drugs Price by Type (2019-2030) & (USD/Pcs)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Other
    Figure 21. Global Liver Cirrhosis Therapeutics Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Liver Cirrhosis Therapeutics Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Liver Cirrhosis Therapeutics Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 24. Global Liver Cirrhosis Therapeutics Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Liver Cirrhosis Therapeutics Drugs Price by Application (2019-2030) & (USD/Pcs)
    Figure 26. North America Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Liver Cirrhosis Therapeutics Drugs Sales Volume (%), (2019-2030)
    Figure 38. United States Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Liver Cirrhosis Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Liver Cirrhosis Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Liver Cirrhosis Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 59. Liver Cirrhosis Therapeutics Drugs Industrial Chain
    Figure 60. Liver Cirrhosis Therapeutics Drugs Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

The global market for Liver Cirrhosis Therapeutics Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Cirrhosis Therapeutics Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liver Cirrhosis Therapeutics Drugs by region & country, by Type, and by Application.

The Liver Cirrhosis Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cirrhosis Therapeutics Drugs.

Market Segmentation